Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients


Biocharacterization of circulating tumor cells (CTCs) in the peripheral blood of advanced breast cancer (ABC) patients may represent a real-time tumor biopsy. We assessed HER2 status on CTCs from blood samples of ABC patients. CTCs were separated and stained using the CellSearch System®. HER2 status was assessed by immunofluorescence and, when technically… (More)
DOI: 10.1007/s10549-009-0461-7


7 Figures and Tables